TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›MSB›Financials
Annual statements · SEC XBRL · FY2016 – FY2025

MESABI TRUST (MSB) financials

Income statement

MESABI TRUST (MSB) income statement, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$9.72M$10.9M$34.5M$47.3M$32.0M$26.0M$71.5M$7.74M$22.9M$98.6M
Revenue growth—12.0%216.8%37.1%-32.4%-18.9%175.4%-89.2%195.3%331.3%
Net income$8.56M$9.76M$33.4M$45.6M$30.1M$23.4M$68.8M$5.31M$19.0M$93.3M
Net margin88.0%89.7%96.9%96.3%94.0%90.2%96.2%68.6%83.0%94.6%

Cash flow

MESABI TRUST (MSB) cash flow, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$8.22M$12.6M$29.5M$45.5M$34.6M$20.8M$62.8M$13.9M$14.6M$93.9M
Dividends paid$8.92M$7.22M$19.5M$36.6M$44.1M$21.9M$37.5M$47.6M$4.59M$17.7M

Balance sheet

MESABI TRUST (MSB) balance sheet, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$2.59M$13.7M$315K$882K$10.2M$12.5M$47.7M$14.0M$24.0M$100M
Total assets$9.82M$14.2M$26.2M$35.5M$23.6M$22.9M$53.9M$14.1M$26.7M$102M
Total liabilities$828K$4.04M$15.6M$18.6M$11.8M$6.45M$23.1M$2.68M$5.72M$78.4M
Shareholders' equity———$16.8M$11.8M$16.5M$30.8M$11.4M$21.0M$23.3M
Shares (wtd avg diluted)13.1M13.1M13.1M13.1M13.1M13.1M13.1M13.1M13.1M13.1M

Every figure is extracted from MESABI TRUST’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is MESABI TRUST's annual revenue?
MESABI TRUST (MSB) reported $98.6M of revenue for fiscal year 2025 — up 331.3% from $22.9M in FY2024, per its annual report filed with the SEC.
Is MESABI TRUST profitable?
Yes — MSB earned $93.3M of net income in FY2025, a 94.6% net margin, per SEC filings.
Does MSB pay a dividend?
Yes — MESABI TRUST paid $17.7M in cash dividends during FY2025, per its SEC cash-flow statement.
Full MSB analysis — verdict, score & filings →Is MSB a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.